Invivyd (IVVD) News Today $0.68 -0.05 (-6.43%) As of 02:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IVVD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Invivyd, Inc. (IVVD) stock price, news, quote & history - Yahoo FinanceJuly 8, 2025 | nz.finance.yahoo.comInvivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination SyndromeJuly 2, 2025 | globenewswire.comInvivyd's (IVVD) Buy Rating Reaffirmed at HC WainwrightJune 26, 2025 | marketbeat.comD. Boral Capital Reaffirms "Buy" Rating for Invivyd (NASDAQ:IVVD)June 26, 2025 | marketbeat.comInvivyd, Inc. Announces Promising Phase 1/2 Data for VYD2311 Monoclonal Antibody Candidate in COVID-19 Prevention and TreatmentJune 26, 2025 | quiverquant.comQInvivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active InfectionJune 26, 2025 | globenewswire.comInvivyd, Inc. (NASDAQ:IVVD) Shares Acquired by Two Sigma Advisers LPJune 8, 2025 | marketbeat.comHC Wainwright Brokers Reduce Earnings Estimates for InvivydMay 31, 2025 | marketbeat.comQ1 Earnings Estimate for Invivyd Issued By HC WainwrightMay 30, 2025 | marketbeat.comH.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue ShortfallMay 29, 2025 | msn.comInvivyd (NASDAQ:IVVD) Price Target Cut to $5.00 by Analysts at HC WainwrightMay 29, 2025 | marketbeat.comInvivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2 VirusMay 27, 2025 | globenewswire.comInvivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell LymphomasMay 23, 2025 | globenewswire.comInvivyd Commends FDA on New Framework for COVID-19 Vaccines Amidst Uncertainty Regarding Booster EfficacyMay 23, 2025 | nasdaq.comInvivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19May 21, 2025 | globenewswire.comEarnings call transcript: Invivyd Q1 2025 sees stock drop amid earnings missMay 16, 2025 | investing.comInvivyd Inc (IVVD) Q1 2025 Earnings Call Highlights: Strategic Shifts and Financial Discipline ...May 16, 2025 | finance.yahoo.comInvivyd Reports Q1 2025 Financial Results and OutlookMay 15, 2025 | tipranks.comINVIVYD Earnings Preview: Recent $IVVD Insider Trading, Hedge Fund Activity, and MoreMay 15, 2025 | nasdaq.comInvivyd, Inc. (IVVD) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comOrbimed Advisors LLC Decreases Stock Position in Invivyd, Inc. (NASDAQ:IVVD)May 15, 2025 | marketbeat.comInvivyd Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 15, 2025 | globenewswire.comMithril II GP LP Buys New Shares in Invivyd, Inc. (NASDAQ:IVVD)May 15, 2025 | marketbeat.comInvivyd, Inc. Submits Citizen Petition to FDA Advocating for Updated COVID-19 Vaccine Development StrategiesMay 14, 2025 | quiverquant.comQInvivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine EfficacyMay 14, 2025 | globenewswire.comInvivyd Initiates Discovery Program for Monoclonal Antibody Targeting Measles Infection and ProphylaxisMay 13, 2025 | nasdaq.comInvivyd begins discovery of measles monoclonal antibodyMay 13, 2025 | investing.comInvivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 13, 2025 | globenewswire.comInvivyd Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for MeaslesMay 12, 2025 | globenewswire.comInvivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025May 8, 2025 | globenewswire.comShort Interest in Invivyd, Inc. (NASDAQ:IVVD) Drops By 15.1%May 5, 2025 | marketbeat.comInvivyd (IVVD) to Release Earnings on ThursdayMay 3, 2025 | marketbeat.comInvivyd, Inc. (NASDAQ:IVVD) Short Interest Up 24.0% in MarchApril 22, 2025 | marketbeat.comInvivyd announces $30M non-dilutive loan facilityApril 21, 2025 | markets.businessinsider.comWhat's Going On With Invivyd Stock On Monday?April 21, 2025 | benzinga.comInvivyd Secures $30 Million Loan from SVBApril 21, 2025 | tipranks.comInvivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley BankApril 21, 2025 | globenewswire.comInvivyd, Inc. (NASDAQ:IVVD) Sees Large Decline in Short InterestMarch 31, 2025 | marketbeat.comInvivyd adds venture capitalist Ajay Royan to boardMarch 28, 2025 | uk.investing.comHC Wainwright Reaffirms Buy Rating for Invivyd (NASDAQ:IVVD)March 27, 2025 | marketbeat.comInvivyd Appoints Ajay Royan to Board of DirectorsMarch 26, 2025 | tipranks.comInvivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of DirectorsMarch 26, 2025 | globenewswire.comInvivyd's (IVVD) "Buy" Rating Reiterated at D. Boral CapitalMarch 21, 2025 | marketbeat.comInvivyd reports FY24 EPS ($1.43) vs. ($1.81) last yearMarch 21, 2025 | markets.businessinsider.comInvivyd (NASDAQ:IVVD) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPSMarch 21, 2025 | marketbeat.comInvivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business HighlightsMarch 20, 2025 | globenewswire.comInvivyd (IVVD) Projected to Post Earnings on ThursdayMarch 20, 2025 | marketbeat.comAre Investors Undervaluing Invivyd, Inc. (IVVD) Right Now?March 12, 2025 | msn.comInvivyd (NASDAQ:IVVD) Receives Buy Rating from D. Boral CapitalMarch 6, 2025 | marketbeat.comInvivyd, Inc. (NASDAQ:IVVD) Short Interest UpdateMarch 5, 2025 | marketbeat.com Get Invivyd News Delivered to You Automatically Sign up to receive the latest news and ratings for IVVD and its competitors with MarketBeat's FREE daily newsletter. Email Address IVVD Media Mentions By Week IVVD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IVVD News Sentiment▼0.930.99▲Average Medical News Sentiment IVVD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IVVD Articles This Week▼23▲IVVD Articles Average Week Get Invivyd News Delivered to You Automatically Sign up to receive the latest news and ratings for IVVD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMRN News Today PRTA News Today BNTC News Today HRTX News Today SNDL News Today VOR News Today AURA News Today ATXS News Today AVTE News Today AVIR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IVVD) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invivyd, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Invivyd With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IVVD Stock Alerts